Mosquito-Borne Arboviruses of African Origin: Review of Key Viruses and Vectors Leo Braack1* , A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Flavivirus: from Structure to Therapeutics Development
life Review Flavivirus: From Structure to Therapeutics Development Rong Zhao 1,2,†, Meiyue Wang 1,2,†, Jing Cao 1,2, Jing Shen 1,2, Xin Zhou 3, Deping Wang 1,2,* and Jimin Cao 1,2,* 1 Key Laboratory of Cellular Physiology, Ministry of Education, Shanxi Medical University, Taiyuan 030001, China; [email protected] (R.Z.); [email protected] (M.W.); [email protected] (J.C.); [email protected] (J.S.) 2 Department of Physiology, Shanxi Medical University, Taiyuan 030001, China 3 Department of Medical Imaging, Shanxi Medical University, Taiyuan 030001, China; [email protected] * Correspondence: [email protected] (D.W.); [email protected] (J.C.) † These authors contributed equally to this work. Abstract: Flaviviruses are still a hidden threat to global human safety, as we are reminded by recent reports of dengue virus infections in Singapore and African-lineage-like Zika virus infections in Brazil. Therapeutic drugs or vaccines for flavivirus infections are in urgent need but are not well developed. The Flaviviridae family comprises a large group of enveloped viruses with a single-strand RNA genome of positive polarity. The genome of flavivirus encodes ten proteins, and each of them plays a different and important role in viral infection. In this review, we briefly summarized the major information of flavivirus and further introduced some strategies for the design and development of vaccines and anti-flavivirus compound drugs based on the structure of the viral proteins. There is no doubt that in the past few years, studies of antiviral drugs have achieved solid progress based on better understanding of the flavivirus biology. -
Morphology and Protein Profiles of Salivary Glands of Filarial Vector Mosquito Mansonia Uniformis; Possible Relation to Blood Feeding Process
Asian Biomedicine Vol. 5 No. 3 June 2011; 353-360 DOI: 10.5372/1905-7415.0502.046 Original article Morphology and protein profiles of salivary glands of filarial vector mosquito Mansonia uniformis; possible relation to blood feeding process Atchara Phumeea, Kanok Preativatanyoub, Kanyarat Kraivichainb, Usavadee Thavarac, Apiwat Tawatsinc, Yutthana Phusupc, Padet Siriyasatienb aMedical Science Program, bDepartment of Parasitology, Faculty of Medicine, Chulalongkorn University, Bangkok 10330; cNational Institute of Health, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand Background: Vector control is a key strategy for eradication of filariasis, but it is limited, possibly due to rapid propagation from global warming. In Thailand, Mansonia mosquitoes are major vectors of filariasis caused by Brugia malayi filarial nematodes. However, little is yet known about vector biology and host-parasite relationship. Objectives: Demonstrate the preliminary data of salivary gland morphology and protein profile of human filarial mosquitoes M. uniformis. Methods: Morphology of M. uniformis salivary gland in both sexes was comparatively studied under a light microscope. Total protein quantization and sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS- PAGE) was performed to compare protein profile between male and female. In addition, quantitative analysis prior to and after blood feeding was made at different times (0, 12, 24, 36, 48, 60, and 72 hours) Results: Total salivary gland protein of males and females was 0.32±0.03 and 1.38±0.02 μg/pair gland, respectively. SDS-PAGE analysis of the female salivary gland protein prior to blood meal demonstrated twelve bands of major proteins at 21, 22, 24, 26, 37, 39, 44, 53, 55, 61, 72, and 100 kDa. -
California Encephalitis Orthobunyaviruses in Northern Europe
California encephalitis orthobunyaviruses in northern Europe NIINA PUTKURI Department of Virology Faculty of Medicine, University of Helsinki Doctoral Program in Biomedicine Doctoral School in Health Sciences Academic Dissertation To be presented for public examination with the permission of the Faculty of Medicine, University of Helsinki, in lecture hall 13 at the Main Building, Fabianinkatu 33, Helsinki, 23rd September 2016 at 12 noon. Helsinki 2016 Supervisors Professor Olli Vapalahti Department of Virology and Veterinary Biosciences, Faculty of Medicine and Veterinary Medicine, University of Helsinki and Department of Virology and Immunology, Hospital District of Helsinki and Uusimaa, Helsinki, Finland Professor Antti Vaheri Department of Virology, Faculty of Medicine, University of Helsinki, Helsinki, Finland Reviewers Docent Heli Harvala Simmonds Unit for Laboratory surveillance of vaccine preventable diseases, Public Health Agency of Sweden, Solna, Sweden and European Programme for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden Docent Pamela Österlund Viral Infections Unit, National Institute for Health and Welfare, Helsinki, Finland Offical Opponent Professor Jonas Schmidt-Chanasit Bernhard Nocht Institute for Tropical Medicine WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research National Reference Centre for Tropical Infectious Disease Hamburg, Germany ISBN 978-951-51-2399-2 (PRINT) ISBN 978-951-51-2400-5 (PDF, available -
Assessment and an Updated List of the Mosquitoes of Saudi Arabia Azzam M
Alahmed et al. Parasites Vectors (2019) 12:356 https://doi.org/10.1186/s13071-019-3579-4 Parasites & Vectors RESEARCH Open Access Assessment and an updated list of the mosquitoes of Saudi Arabia Azzam M. Alahmed1, Kashif Munawar1*, Sayed M. S. Khalil1,2 and Ralph E. Harbach3 Abstract Background: Mosquito-borne pathogens are important causes of diseases in the Kingdom of Saudi Arabia. Knowl- edge of the mosquito fauna is needed for the appropriate control of the vectors that transmit the pathogens and prevent the diseases they cause. An important frst step is to have an up-to-date list of the species known to be present in the country. Original occurrence records were obtained from published literature and critically scrutinized to compile a list of the mosquito species that occur within the borders of the Kingdom. Results: Fifty-one species have been recorded in the Kingdom; however, the occurrence of two of these species is unlikely. Thus, the mosquito fauna of the Kingdom comprises 49 species that include 18 anophelines and 31 culicines. Published records are provided for each species. Problematic records based on misidentifcations and inappropriate sources are discussed and annotated for clarity. Conclusion: Integrated morphological and molecular methods of identifcation are needed to refne the list of spe- cies and accurately document their distributions in the Kingdom. Keywords: Culicidae, Mosquitoes, Saudi Arabia, Vectors Background Mosquito-borne pathogens, including Plasmodium Te Arabian Peninsula (c.3 million km2) includes the species, dengue virus, Rift Valley fever virus and micro- Kingdom of Saudi Arabia (KSA), Oman, Qatar, United flariae, cause diseases in the KSA [9–11]. -
Why Aedes Aegypti?
Am. J. Trop. Med. Hyg., 98(6), 2018, pp. 1563–1565 doi:10.4269/ajtmh.17-0866 Copyright © 2018 by The American Society of Tropical Medicine and Hygiene Perspective Piece Mosquito-Borne Human Viral Diseases: Why Aedes aegypti? Jeffrey R. Powell* Yale University, New Haven, Connecticut Abstract. Although numerous viruses are transmitted by mosquitoes, four have caused the most human suffering over the centuries and continuing today. These are the viruses causing yellow fever, dengue, chikungunya, and Zika fevers. Africa is clearly the ancestral home of yellow fever, chikungunya, and Zika viruses and likely the dengue virus. Several species of mosquitoes, primarily in the genus Aedes, have been transmitting these viruses and their direct ancestors among African primates for millennia allowing for coadaptation among viruses, mosquitoes, and primates. One African primate (humans) and one African Aedes mosquito (Aedes aegypti) have escaped Africa and spread around the world. Thus it is not surprising that this native African mosquito is the most efficient vector of these native African viruses to this native African primate. This makes it likely that when the next disease-causing virus comes out of Africa, Ae. aegypti will be the major vector to humans. Mosquito-borne viruses (arboviruses) have been afflicting The timeline for the spread of Ae. aegypti is reasonably clear humans for millennia and continue to cause immeasurable and is consistent with epidemiologic records. Beginning in the suffering. While not the only mosquito-borne viruses, the fol- sixteenth century, European ships to the New World stopped lowing four have been the most widespread and notorious in in West Africa to pick up native Africans for the slave trade8 terms of severity of diseases and number of humans affected: and very likely picked up Ae. -
MDHHS BOL Mosquito-Borne and Tick-Borne Disease Testing
MDHHS BUREAU OF LABORATORIES MOSQUITO-BORNE AND TICK-BORNE DISEASE TESTING MOSQUITO-BORNE DISEASES The Michigan Department of Health and Human Services Bureau of Laboratories (MDHHS BOL) offers comprehensive testing on clinical specimens for the following viral mosquito-borne diseases (also known as arboviruses) of concern in Michigan: California Group encephalitis viruses including La Crosse encephalitis virus (LAC) and Jamestown Canyon virus (JCV), Eastern Equine encephalitis virus (EEE), St. Louis encephalitis virus (SLE), and West Nile virus (WNV). Testing is available free of charge through Michigan healthcare providers for their patients. Testing for mosquito-borne viruses should be considered in patients presenting with meningitis, encephalitis, or other acute neurologic illness in which an infectious etiology is suspected during the summer months in Michigan. Methodologies include: • IgM detection for five arboviruses (LAC, JCV, EEE, SLE, WNV) • Molecular detection (PCR) for WNV only • Plaque Reduction Neutralization Test (PRNT) is also available and may be performed on select samples when indicated The preferred sample for arbovirus serology at MDHHS BOL is cerebral spinal fluid (CSF), followed by paired serum samples (acute and convalescent). In cases where CSF volume may be small, it is recommended to also include an acute serum sample. Please see the following document for detailed instructions on specimen requirements, shipping and handling instructions: http://www.michigan.gov/documents/LSGArbovirus_IgM_Antibody_Panel_8347_7.doc Michigan residents may also be exposed to mosquito-borne viruses when traveling domestically or internationally. In recent years, the most common arboviruses impacting travelers include dengue, Zika and chikungunya virus. MDHHS has the capacity to perform PCR for dengue, chikungunya and Zika virus and IgM for dengue and Zika virus to confirm commercial laboratory arbovirus findings or for complicated medical investigations. -
Zika Virus Outside Africa Edward B
Zika Virus Outside Africa Edward B. Hayes Zika virus (ZIKV) is a flavivirus related to yellow fever, est (4). Serologic studies indicated that humans could also dengue, West Nile, and Japanese encephalitis viruses. In be infected (5). Transmission of ZIKV by artificially fed 2007 ZIKV caused an outbreak of relatively mild disease Ae. aegypti mosquitoes to mice and a monkey in a labora- characterized by rash, arthralgia, and conjunctivitis on Yap tory was reported in 1956 (6). Island in the southwestern Pacific Ocean. This was the first ZIKV was isolated from humans in Nigeria during time that ZIKV was detected outside of Africa and Asia. The studies conducted in 1968 and during 1971–1975; in 1 history, transmission dynamics, virology, and clinical mani- festations of ZIKV disease are discussed, along with the study, 40% of the persons tested had neutralizing antibody possibility for diagnostic confusion between ZIKV illness to ZIKV (7–9). Human isolates were obtained from febrile and dengue. The emergence of ZIKV outside of its previ- children 10 months, 2 years (2 cases), and 3 years of age, ously known geographic range should prompt awareness of all without other clinical details described, and from a 10 the potential for ZIKV to spread to other Pacific islands and year-old boy with fever, headache, and body pains (7,8). the Americas. From 1951 through 1981, serologic evidence of human ZIKV infection was reported from other African coun- tries such as Uganda, Tanzania, Egypt, Central African n April 2007, an outbreak of illness characterized by rash, Republic, Sierra Leone (10), and Gabon, and in parts of arthralgia, and conjunctivitis was reported on Yap Island I Asia including India, Malaysia, the Philippines, Thailand, in the Federated States of Micronesia. -
Data-Driven Identification of Potential Zika Virus Vectors Michelle V Evans1,2*, Tad a Dallas1,3, Barbara a Han4, Courtney C Murdock1,2,5,6,7,8, John M Drake1,2,8
RESEARCH ARTICLE Data-driven identification of potential Zika virus vectors Michelle V Evans1,2*, Tad A Dallas1,3, Barbara A Han4, Courtney C Murdock1,2,5,6,7,8, John M Drake1,2,8 1Odum School of Ecology, University of Georgia, Athens, United States; 2Center for the Ecology of Infectious Diseases, University of Georgia, Athens, United States; 3Department of Environmental Science and Policy, University of California-Davis, Davis, United States; 4Cary Institute of Ecosystem Studies, Millbrook, United States; 5Department of Infectious Disease, University of Georgia, Athens, United States; 6Center for Tropical Emerging Global Diseases, University of Georgia, Athens, United States; 7Center for Vaccines and Immunology, University of Georgia, Athens, United States; 8River Basin Center, University of Georgia, Athens, United States Abstract Zika is an emerging virus whose rapid spread is of great public health concern. Knowledge about transmission remains incomplete, especially concerning potential transmission in geographic areas in which it has not yet been introduced. To identify unknown vectors of Zika, we developed a data-driven model linking vector species and the Zika virus via vector-virus trait combinations that confer a propensity toward associations in an ecological network connecting flaviviruses and their mosquito vectors. Our model predicts that thirty-five species may be able to transmit the virus, seven of which are found in the continental United States, including Culex quinquefasciatus and Cx. pipiens. We suggest that empirical studies prioritize these species to confirm predictions of vector competence, enabling the correct identification of populations at risk for transmission within the United States. *For correspondence: mvevans@ DOI: 10.7554/eLife.22053.001 uga.edu Competing interests: The authors declare that no competing interests exist. -
Arbovirus Discovery in Central African Republic (1973-1993): Zika, Bozo
Research Article Annals of Infectious Disease and Epidemiology Published: 13 Nov, 2017 Arbovirus Discovery in Central African Republic (1973- 1993): Zika, Bozo, Bouboui, and More Jean François Saluzzo1, Tom Vincent2, Jay Miller3, Francisco Veas4 and Jean-Paul Gonzalez5* 1Fab’entech, Lyon, France 2O’Neill Institute for National and Global Health Law, Georgetown University Law Center, Washington, DC, USA 3Department of Infectious Disease, Health Security Partners, Washington, DC, USA 4Laboratoire d’Immunophysiopathologie Moléculaire Comparée-UMR- Ministère de la Défense3, Institute de Recherche pour le Développement, Montpellier, France 5Center of Excellence for Emerging and Zoonotic Animal Disease, Kansas State University, Manhattan, KS, USA Abstract The progressive research on yellow fever and the subsequent emergence of the field of arbovirology in the 1950s gave rise to the continued development of a global arbovirus surveillance network with a specific focus on human pathogenic arboviruses of the tropical zone. Though unknown at the time, some of the arboviruses studies would emerge within the temperate zone decades later (e.g.: West Nile, Zika, Chikungunya). However, initial research by the surveillance network was heavily focused on the discovery, isolation, and characterization of numerous arbovirus species. Global arboviral surveillance has revealed a cryptic circulation of several arboviruses, mainly in wild cycles of the tropical forest. Although there are more than 500 registered arbovirus species, a mere one third has proved to be pathogenic to humans (CDC, 2015). Indeed, most known arboviruses did not initially demonstrate a pathogenicity to humans or other vertebrates, and were considered “orphans” (i.e. without known of vertebrate hosts). As a part of this global surveillance network, the Institut Pasteur International Network has endeavored to understand the role played by arboviruses in the etiology of febrile syndromes of unknown origin as one of its research missions. -
RESCON 2020 Proceedings
POSTGRADUATE INSTITUTE OF SCIENCE UNIVERSITY OF PERADENIYA SRI LANKA PGIS RESEARCH CONGRESS 2020 PROCEEDINGS 26th - 28th November 2020 Copyright © 2020 by Postgraduate Institute of Science All rights reserved. No part of this publication may be reproduced, distributed, stored in a retrieval system, and transmitted in any form or by any means, including photocopying, recording, or other electronic or mechanical methods, without the prior written permission of the publisher. ISBN 978-955-8787-10-6 Published by Postgraduate Institute of Science (PGIS) University of Peradeniya Peradeniya 20400 SRI LANKA Printed by Sanduni Offset Printers (Pvt) Ltd, 1/4, Sarasavi Uyana Goodshed Road, Sarasavi Uyana, Peradeniya 20400, Sri Lanka Printed in the Democratic Socialist Republic of Sri Lanka ii TABLE OF CONTENTS Message from the Director, Postgraduate Institute of Science ....................................... v Message from the Congress Chairperson ..................................................................... vii Message from the Editor-in-Chief .................................................................................ix Message from the Chief Guest .......................................................................................xi Editorial Board ............................................................................................................ xiii Academic Coordinators of the Virtual Technical Sessions .........................................xiv A Brief Biography of the Keynote Speaker ................................................................. -
An Overview of Mosquito Vectors of Zika Virus
Microbes and Infection xxx (2018) 1e15 Contents lists available at ScienceDirect Microbes and Infection journal homepage: www.elsevier.com/locate/micinf An overview of mosquito vectors of Zika virus Sebastien Boyer a, Elodie Calvez b, Thais Chouin-Carneiro c, Diawo Diallo d, * Anna-Bella Failloux e, a Institut Pasteur of Cambodia, Unit of Medical Entomology, Phnom Penh, Cambodia b Institut Pasteur of New Caledonia, URE Dengue and Other Arboviruses, Noumea, New Caledonia c Instituto Oswaldo Cruz e Fiocruz, Laboratorio de Transmissores de Hematozoarios, Rio de Janeiro, Brazil d Institut Pasteur of Dakar, Unit of Medical Entomology, Dakar, Senegal e Institut Pasteur, URE Arboviruses and Insect Vectors, Paris, France article info abstract Article history: The mosquito-borne arbovirus Zika virus (ZIKV, Flavivirus, Flaviviridae), has caused an outbreak Received 6 December 2017 impressive by its magnitude and rapid spread. First detected in Uganda in Africa in 1947, from where it Accepted 15 January 2018 spread to Asia in the 1960s, it emerged in 2007 on the Yap Island in Micronesia and hit most islands in Available online xxx the Pacific region in 2013. Subsequently, ZIKV was detected in the Caribbean, and Central and South America in 2015, and reached North America in 2016. Although ZIKV infections are in general asymp- Keywords: tomatic or causing mild self-limiting illness, severe symptoms have been described including neuro- Arbovirus logical disorders and microcephaly in newborns. To face such an alarming health situation, WHO has Mosquito vectors Aedes aegypti declared Zika as an emerging global health threat. This review summarizes the literature on the main fi Vector competence vectors of ZIKV (sylvatic and urban) across all the ve continents with special focus on vector compe- tence studies. -
Efficacy of Vaccines in Animal Models of Ebolavirus Disease
Supplemental Table 1. Efficacy of vaccines in animal models of Ebolavirus disease. Vaccines Immunization Schedule Mouse Model Guinea Pig Model NHP Model Virus Vectors HPIV3 Immunogens Guinea Pigs: Complete protection Complete protection HPIV3 ∆HN-F/ EBOV GP IN 4 x 106 PFU of HPIV3 with HPIV3 ∆HN-F/EBOV with 2 doses of [1] ∆HN-F/EBOV GP or GP, HPIV3/EBOV GP, or HPIV3/EBOV GP [3] EBOV GP [1-3] HPIV3/EBOV GP [1] HPIV3/EBOV NP [1, 2] No advantage to EBOV NP [2] IN 105.3 PFU of HPIV/EBOV Strong humoral response bivalent vaccines EBOV GP + NP [3] GP or NP [2] EBOV GP +GM-CSF [3] HPIV3- NHPs: 6 IN plus IT 4 x 10 TCID50 of HPIV3/EBOV GP, HPIV3/EBOV GP+GM-CSF, HPIV3/EBOVGP NP or 2 x 7 10 TCID50 of HPIV3/EBOV GP for 1–2 doses [3] RABV ∆GP/EBOV GP Mice: IM 5 x 105 FFU Complete protection with (Live attenuated) [4] either vector RABV/EBOV GP fused to EBOV GP incorporation into GCD of RABV virions not dependent on (inactivated) [4] RABV GCD Human Ad5 Immunogens Mice: With induced preexisting Ad5 With systemically CMVEBOV GP [5-9] IN, PO, IM 1 x 1010 [6] to 5 immunity, complete induced preexisting Ad5 CAGoptEBOV GP [8, 9] x 1010 [5] particles of protection with only IN immunity, complete Ad5/CMVEBOV GP Ad5/CMVEBOV GP [5] protection with IN IP 1 x 108 PFU With no Ad5 immunity: Ad5/CMVEBOV GP [8] Ad5/CMVEBOV GP[7] complete protection With mucosally induced IM 1 x 104–1 x 107 IFU of regardless of route [5-7, 9] preexisting Ad5 Ad5/CMVEBOV GP or 1 x Mucosal immunization Ad5- immunity, 83% 104–1 x 106 IFU of EBOV GP increased cellular